Literature DB >> 10548407

Approaching the patient with chronic malabsorption syndrome.

G C Harewood1, J A Murray.   

Abstract

The causes of chronic malabsorption may be categorized as decreased intestinal absorption, most commonly caused by celiac sprue; or maldigestion caused by pancreatic insufficiency. The initial step in the evaluation of these patients should include stool studies to confirm fat malabsorption. If fat malabsorption is confirmed, endoscopy with small-bowel biopsies and aspirates for bacterial culture usually follows. A normal endoscopic examination should lead to assessment of pancreatic function. In the setting of normal pancreatic function and the absence of bile acid deficiency, a barium radiograph of the small bowel should be made, looking for anatomical abnormalities. Celiac sprue is an intolerance to gluten caused by a combination of genetic, environmental, and immunologic factors. It classically causes malabsorption. However, it is likely that many patients who exhibit only minor manifestations of the disease go unrecognized and untreated. A presumed diagnosis of celiac sprue is confirmed after a clinical and endoscopic response to a gluten-free diet. Serological markers are available with high degrees of sensitivity and specificity, but duodenal biopsy remains the gold standard for diagnosis. A minority of patients are unresponsive to a gluten-free diet, and intestinal lymphoma should be suspected in these cases.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10548407

Source DB:  PubMed          Journal:  Semin Gastrointest Dis        ISSN: 1049-5118


  2 in total

Review 1.  Routine disaccharidase testing: are we there yet?

Authors:  Antone R Opekun; Bruno P Chumpitazi; Mustafa M Abdulsada; Buford L Nichols
Journal:  Curr Opin Gastroenterol       Date:  2020-03       Impact factor: 2.741

2.  Chronic diarrhea as the presenting feature of primary systemic AL amyloidosis: serendipity or delayed diagnosis?

Authors:  Chen Wang; Yue Li; Yali Jin; Weixun Zhou; Yanlin Zhu; Fang Yao; Jiaming Qian
Journal:  BMC Gastroenterol       Date:  2013-04-24       Impact factor: 3.067

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.